Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sana Biotechnology, Inc. (SANA)
|
Add to portfolio |
|
|
|
| Price: |
$15.40
| | Metrics |
| OS: |
196.9
|
M
| |
-110
|
% ROE
|
| Market cap: |
$3.03
|
B
| |
|
|
|
Net cash:
|
$174
|
M
| |
$0.88
|
per share
|
|
EV:
|
$2.86
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($2.04)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 357.4 | 0.0 | 0.0 | 0.0 | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross profit | 357.4 | 0.0 | 0.0 | 0.0 | |
| Gross margin | 100.0% | | | | |
| Research and development | 285.9 | 248.6 | 132.9 | 99.6 | |
| General and administrative | 71.6 | 50.4 | 28.3 | 21.8 | |
| EBIT | -272.6 | -356.9 | -286.1 | -141.2 | |
| EBIT margin | -76.3% | | | | |
| Pre-tax income | -269.5 | -355.9 | -285.3 | -138.3 | |
| Income taxes | 0.0 | 0.0 | 0.0 | -7.5 | |
| Tax rate | 0.0% | 0.0% | 0.0% | 5.5% | |
| Net income | -269.5 | -355.9 | -285.3 | -130.8 | |
| Net margin | -75.4% | | | | |
| |
| Diluted EPS | ($1.43) | ($2.14) | ($21.92) | ($26.67) | |
| Shares outstanding (diluted) | 188.3 | 166.4 | 13.0 | 4.9 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|